Functional role of exogenous administration of substance P in chronic constriction injury model of neuropathic pain in gerbils

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 1, 2003, Pages 17-25

  Meert, Theo F ^a   Vissers, Kris ^b   Geenen, Frank ^a   Kontinen, Vesa K ^c  

^a PRD Johnson and Johnson   (Belgium)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Allodynia; Chronic constriction injury; Neurokinins; Neuropathic pain; NK 1 receptors

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR; R 116301; SUBSTANCE P; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC CONSTRICTION INJURY; CHRONIC DISEASE; CONTROLLED STUDY; GERBIL; HYPERSENSITIVITY; MALE; NERVE COMPRESSION; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCIATIC NERVE; SCIATIC NEUROPATHY;

ANIMALS; CONSTRICTION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GERBILLINAE; MALE; PAIN MEASUREMENT; RECEPTORS, NEUROKININ-1; SCIATIC NEUROPATHY; SUBSTANCE P;

GERBILLINAE;

EID: 1642398355     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00187-4     Document Type: Article

References (58)

1. Aanonsen L.M., Kajander K.C., Bennett G.J., Seybold V.S. Autoradiographic analysis of 125I-substance P binding in rat spinal cord following chronic constriction injury of the sciatic nerve. Brain Res. 596(1-2):1992;259-268.
2. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain. 41(2):1990;235-251.
3. Attal N., Filliatreau G., Perrot S., Jazat F., Di Giamberardino L., Guilbaud G. Behavioural pain-related disorders and contribution of the saphenous nerve in crush and chronic constriction injury of the rat sciatic nerve. Pain. 59(2):1994;301-312.
4. Bai Y.H., Takemitsu M., Atsuta Y., Matsuno T. Peripheral mononeuropathy induced by loose ligation of the sciatic nerve in the rat: behavioral, electrophysiological and histopathologic studies. Exp. Anim. 48(2):1999;87-94.
5. Basile S., Khalil Z., Helme R.D. Skin vascular reactivity to the neuropeptide substance P in rats with peripheral mononeuropathy. Pain. 52(2):1993;217-222.
6. Behbehani M.M., Dollberg-Stolik O. Partial sciatic nerve ligation results in an enlargement of the receptive field and enhancement of the response of dorsal horn neurons to noxious stimulation by an adenosine agonist. Pain. 58:1994;421-428.
7. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33(1):1988;87-107.
8. Beresford I.J., Birch P.J., Hagan R.M., Ireland S.J. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345. Br. J. Pharmacol. 104(2):1991;292-293.
9. Boersma F.P., Meert T.F., Vercauteren M. Spinal sufentanil in rats: Part I. Epidural versus intrathecal sufentanil and morphine. Acta Anaesthesiol. Scand. 36(2):1992;187-192.
10. Boyce S., Hill R.G. Devor M., Rowbotham M.C., Wiesenfeld-Hallin Z. Proceedings of the 9th World Congress on Pain. 2000;313-324 IASP Press, Seattle.
11. Cahill C.M., Coderre T.J. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain. 95(3):2002;277-285.
12. Campbell E.A., Gentry C.T., Patel S., Panesar M.S., Walpole C.S., Urban L. Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience. 87(3):1998;527-532.
13. Carlton S.M., Dougherty P.M., Pover C.M., Coggeshall R.E. Neuroma formation and numbers of axons in a rat model of experimental peripheral neuropathy. Neurosci. Lett. 131(1):1991;88-92.
14. Carlton S.M., Lekan H.A., Kim S.H., Chung J.M. Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate. Pain. 56(2):1994;155-166.
15. Carlton S.M., Zhou S., Coggeshall R.E. Localization and activation of substance P receptors in unmyelinated axons of rat glabrous skin. Brain Res. 734:1996;103-108.
16. Challet E., Dugovic C., Turek F.W., Olivier Van R. The selective neurokinin 1 receptor antagonist R116301 modulates photic responses of the hamster circadian system. Neuropharmacology. 40(3):2001;408-415.
17. Coderre T.J., Melzack R. Central neural mediators of secondary hyperalgesia following heat injury in rats: neuropeptides and excitatory amino acids. Neurosci. Lett. 131(1):1991;71-74.
18. Coggeshall R.E., Dougherty P.M., Pover C.M., Carlton S.M. Is large myelinated fiber loss associated with hyperalgesia in a model of experimental peripheral neuropathy in the rat? Pain. 52(2):1993;233-242.
19. Cohen R.H., Perl E.R. Contributions of arachidonic acid derivatives and substance P to the sensitization of cutaneous nociceptors. J. Neurophysiol. 64(2):1990;457-464.
20. Coudore-Civiale M.A., Courteix C., Eschalier A., Fialip J. Effect of tachykinin receptor antagonists in experimental neuropathic pain. Eur. J. Pharmacol. 361(2-3):1998;175-184.
21. Drapeau G., D'Orleans-Juste P., Dion S., Rhaleb N.E., Rouissi N.E., Regoli D. Selective agonists for substance P and neurokinin receptors. Neuropeptides. 10(1):1987;43-54.
22. Fitzgerald M., Lynn B. The weak excitation of some cutaneous receptors in cats and rabbits by synthetic substance P. [proceedings] J. Physiol. (London). 293:1979;66P-67P.
23. Garrison C.J., Dougherty P.M., Carlton S.M. Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats. Brain Res. 607(1-2):1993;205-214.
24. Ghoul W., Volsi G.L., Weinberg R.J., Rustioni A. Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerve of rats. Brain Res. Bull. 30(3-4):1993;453-459.
25. Gonzalez M.I., Field M.J., Hughes J., Singh L. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 294(2):2000;444-450.
26. Hama A.T., Sagen J., Pappas G.D. Morphological characterization of dorsal horn spinal neurons in rats with unilateral constriction nerve injury: a preliminary study. Neurol. Res. 16(4):1994;297-304.
27. Herzberg U., Murtaugh M., Beitz A.J. Chronic pain and immunity: mononeuropathy alters immune responses in rats. Pain. 59(2):1994;219-225.
28. Herzberg U., Brown D.R., Mullett M.A., Beitz A.J. Increased delayed type hypersensitivity in rats subjected to unilateral mononeuropathy is mediated by neurokinin-1 receptors. J. Neuroimmunol. 65(2):1996;119-124.
29. Hong Y., Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience. 63(3):1994;827-836.
30. Kellstein D.E., Price D.D., Hayes R.L., Mayer D.J. Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neurons. Brain Res. 526(2):1990;291-298.
31. Klir J.J., Heath J.E., Bennani N. An infrared thermographic study of surface temperature in relation to external thermal stress in the Mongolian gerbil, Meriones unguiculatus. Comp. Biochem. Physiol., A. 96(1):1990;141-146.
32. Koltzenburg M., Wall P.D., McMahon S.B. Does the right side know what the left is doing? Trends Neurosci. 22(3):1999;122-127.
33. Lembeck F., Gamse R. Lack of algesic effect of substance P on paravascular pain receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 299(3):1977;295-303.
34. Ma W., Bisby M.A. Increase of preprotachykinin mRNA and substance P immunoreactivity in spared dorsal root ganglion neurons following partial sciatic nerve injury. Eur. J. Neurosci. 10(7):1998;2388-2399.
35. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 26(5):1995;911-944.
36. Maggi C.A. The effects of tachykinins on inflammatory and immune cells. Regulatory Pept. 70(2-3):1997;75-90.
37. Malmberg A.B., Basbaum A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain. 76(1-2):1998;215-222.
38. Mansikka H., Shiotani M., Winchurch R., Raja S.N. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiology. 90(6):1999;1643-1649.
39. Mansikka H., Sheth R.N., DeVries C., Lee H., Winchurch R., Raja S.N. Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Exp. Neurol. 162(2):2000;343-349.
40. Marchand J.E., Wurm W.H., Kato T., Kream R.M. Altered tachykinin expression by dorsal root ganglion neurons in a rat model of neuropathic pain. Pain. 58(2):1994;219-231.
41. Martinez-Caro L., Laird J.M. Allodynia and hyperalgesia evoked by sciatic mononeuropathy in NKI receptor knockout mice. NeuroReport. 11(6):2000;1213-1217.
42. Matsumura H., Sakurada T., Hara A., Sakurada S., Kisara K. Characterization of the hyperalgesic effect induced by intrathecal injection of substance P. Neuropharmacology. 24(5):1985;421-426.
43. McLachlan E.M., Hu P. Axonal sprouts containing calcitonin gene-related peptide and substance P form pericellular baskets around large diameter neurons after sciatic nerve transection in the rat. Neuroscience. 84(4):1998;961-965.
44. Megens A.A., Ashton D., Vermeire J.C., Vermote P.C., Hens K.A., Hillen L.C.et al. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl) benzoyl]-2-(phenylmethyl)-4-piper idinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. J. Pharmacol. Exp. Ther. 302(2):2002;696-709.
45. Mizumura K., Sato J., Kumazawa T. Effects of prostaglandins and other putative chemical intermediaries on the activity of canine testicular polymodal receptors studied in vitro. Pflügers Arch. 408(6):1987;565-572.
46. Moller K.A., Johansson B., Berge O.G. Assessing mechanical allodynia in the rat paw with a new electronic algometer. J. Neurosci. Methods. 84(1-2):1998;41-47.
47. Nahin R.L., Ren K., De Leon M., Ruda M. Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain. 58(1):1994;95-108.
48. Nakamura-Craig M., Smith T.W. Substance P and peripheral inflammatory hyperalgesia. Pain. 38(1):1989;91-98.
49. Noguchi K., Dubner R., De Leon M., Senba E., Ruda M.A. Axotomy induces preprotachykinin gene expression in a subpopulation of dorsal root ganglion neurons. J. Neurosci. Res. 37(5):1994;596-603.
50. Oufara S., Barre H., Rouanet J.L., Chatonnet J. Adaptation to extreme ambient temperatures in cold-acclimated gerbils and mice. Am. J. Physiol. 253(1 Pt 2):1987;R39-R45.
51. Quartara L., Maggi C.A. The tachykinin NK1 receptor: Part II. Distribution and pathophysiological roles. Neuropeptides. 32(1):1998;1-49.
52. Romerio S.C., Linder L., Haefeli W.E. Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation. Clin. Pharmacol. Ther. 66(5):1999;522-527.
53. Skilling S.R., Harkness D.H., Larson A.A. Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord. Neurosci. Lett. 139(1):1992;92-96.
54. Snijdelaar D.G., Dirksen R., Slappendel R., Crul B.J. Substance P. Eur. J. Pain. 4(2):2000;121-135.
55. Wagner R., DeLeo J.A., Coombs D.W., Willenbring S., Fromm C. Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model. Brain Res. 629(2):1993;323-326.
56. Xu J., Pollock C.H., Kajander K.C. Chromic gut suture reduces calcitonin-gene-related peptide and substance P levels in the spinal cord following chronic constriction injury in the rat. Pain. 64(3):1996;503-509.
57. Yasphal K., Wright D.M., Henry J.L. Substance P reduces tail-flick latency: implications for chronic pain syndromes. Pain. 14(2):1982;155-167.
58. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain. 16:1983;109-110.